Klimov A I, Egorov A Y, Gushchina M I, Medvedeva T E, Gamble W C, Rudenko L G, Alexandrova G I, Cox N J
Influenza Branch G-16, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
J Gen Virol. 1995 Jun;76 ( Pt 6):1521-5. doi: 10.1099/0022-1317-76-6-1521.
We previously reported that the A/Leningrad/134/47/57 (H2N2) cold-adapted virus (A/Len/47) used in preparing reassortant live attenuated vaccines for children acquired 14 (11 coding) mutations in genes coding for proteins other than haemagglutinin and neuraminidase during cold-adaptation. Preservation of these mutations in genomes of viruses isolated from children on the second, fifth, or eighth day after vaccination was examined by sequence analysis. The sequence data demonstrated that all nine coding mutations selected for examination were conserved in the genomes of all 11 strains investigated, indicating that the mutations accompanying cold-adaptation and attenuation of the A/Len/47 master vaccine are highly stable.
我们之前报道过,用于制备儿童重组减毒活疫苗的A/列宁格勒/134/47/57(H2N2)冷适应病毒(A/列宁格勒/47)在冷适应过程中,其血凝素和神经氨酸酶以外的蛋白质编码基因获得了14个(11个编码)突变。通过序列分析检测了接种疫苗后第二天、第五天或第八天从儿童中分离出的病毒基因组中这些突变的保留情况。序列数据表明,所检测的全部9个编码突变在所有11株被研究病毒的基因组中均保守,这表明伴随A/列宁格勒/47主疫苗冷适应和减毒的突变高度稳定。